FDA Approves Genentech's Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
FDA Approves Genentech's Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
7 months ago
finanznachrichten.de
Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). It is also the most common type of NHL, accounting for one out of every three lymphomas and affecting almost 31,000 people in the U.S. Learn more about Lamar’s journey with this condition. | Genentech
0:06
Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). It is also the most common type of NHL, accounting for one out of every three lymphomas and affecting almost 31,000 people in the U.S. Learn more about Lamar’s journey with this condition. | Genentech
23.2K viewsJul 26, 2024
FacebookGenentech
Many people with small cell lung cancer (#SCLC) are diagnosed at an advanced stage, known as extensive-stage SCLC (ES-SCLC), where treatment options are limited. For patients and caregivers, every decision made during the window after diagnosis can profoundly influence outcomes. Learn more about ES-SCLC and why fast action matters: http://spr.ly/61847c0jY | Genentech
0:26
Many people with small cell lung cancer (#SCLC) are diagnosed at an advanced stage, known as extensive-stage SCLC (ES-SCLC), where treatment options are limited. For patients and caregivers, every decision made during the window after diagnosis can profoundly influence outcomes. Learn more about ES-SCLC and why fast action matters: http://spr.ly/61847c0jY | Genentech
37.1K views6 months ago
FacebookGenentech
Dr. Laurie Sehn is a hematologist and clinical professor who often treats people living with diffuse large B-cell lymphoma (DLBCL), the most common form of aggressive non-Hodgkin’s lymphoma. Hear more from her about the disease and the importance of effective therapy when treated for the first time. | Genentech
0:25
Dr. Laurie Sehn is a hematologist and clinical professor who often treats people living with diffuse large B-cell lymphoma (DLBCL), the most common form of aggressive non-Hodgkin’s lymphoma. Hear more from her about the disease and the importance of effective therapy when treated for the first time. | Genentech
307K viewsJul 30, 2024
FacebookGenentech
Dr. Laurie Sehn is a hematologist and clinical professor who often treats people living with diffuse large B-cell lymphoma (DLBCL), the most common form of aggressive non-Hodgkin’s lymphoma. Hear more from her about the disease and the importance of effective therapy when treated for the first time. | Genentech
0:34
Dr. Laurie Sehn is a hematologist and clinical professor who often treats people living with diffuse large B-cell lymphoma (DLBCL), the most common form of aggressive non-Hodgkin’s lymphoma. Hear more from her about the disease and the importance of effective therapy when treated for the first time. | Genentech
152.9K viewsJul 30, 2024
FacebookGenentech
Today, the FDA granted accelerated approval for a new targeted medicine that treats the most aggressive form of #lymphoma. Watch our video to learn more about diffuse large B-cell lymphoma (DLBCL): http://bit.ly/2I5sd5L | Genentech
0:31
Today, the FDA granted accelerated approval for a new targeted medicine that treats the most aggressive form of #lymphoma. Watch our video to learn more about diffuse large B-cell lymphoma (DLBCL): http://bit.ly/2I5sd5L | Genentech
63.7K viewsJun 10, 2019
FacebookGenentech
Single cell & label free binding affinity: applications with Genentech
Single cell & label free binding affinity: applications with Genentech
Apr 27, 2021
labroots.com
1:04
🍿Everyone, please take your seats, a first-of-its-kind musical comedy is coming soon to a screen near you!🍿 The SMA Community’s own Shane and Hannah will be taking the stage in the musical comedy livestream “Most Likely Not To…”! This show spotlights ableism in all its forms while highlighting the realities of traveling while disabled. Tune in this Rare Disease Day on Feb 29 at 3pm PT / 6pm ET! Support for #MostLikelyNotTo is provided by our SMA My Way program. | Genentech
1.3M viewsFeb 16, 2024
FacebookGenentech
1:17
When Dukhi was diagnosed with small cell lung cancer (SCLC), her world changed in an instant. Her daughter, Mitzi, immediately stepped into the role of a caregiver to help Dukhi navigate the unknown that comes with a cancer diagnosis. Hear from Mitzi as she shares her experience as a caregiver, offering insights into the challenges and emotional journey of supporting a loved one with cancer. | Genentech
355 views5 months ago
FacebookGenentech
Fda approves Genentech's Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancer
7 months ago
marketscreener.com
0:18
LaShaun Coleman is a Therapeutic Area Manager at our company who was diagnosed with breast cancer at 36 years old. Her cancer journey is a testament to the importance of listening to your body, advocating for your health, and prioritizing regular cancer screenings. Now, as a breast cancer survivor, LaShaun is an advocate for regular cancer screenings and a firm believer in trusting your gut. Hear from LaShaun and learn more about our Cancer Screen Week initiative. | Genentech
627.3K viewsNov 27, 2024
FacebookGenentech
0:11
What if we could alter cells to help us fight disease more effectively, or transplant cells to regenerate tissue and restore lost function? Cell therapy is a promising therapeutic strategy that aims to turn cells into living medicines. By replacing or enhancing cells to effectively carry out vital roles, cell therapy can become a powerful treatment for cancer, eye diseases and more. Click to read about how our robust collaborations are complementing our own efforts to drive forward the discovery
30.4K viewsJan 9, 2023
FacebookGenentech
0:53
B cells that pass from the blood into the brain may be a key to understanding multiple sclerosis. Dr. Stephen Hauser of UCSF explains how the discovery of the B cell has shifted our approach to treating MS. Learn more: http://ow.ly/Nice309gxqN | Genentech
75.6K viewsFeb 23, 2017
FacebookGenentech
0:54
In S5E08 of our podcast, Two Scientists Walk Into a Bar, our drug discovery leader Karin Briner, covers the many types of medicines scientists can develop to treat a disease, including antibodies, gene and cell therapies, and RNA-based therapies. Listen to the full episode to learn more about the innovative therapeutic modalities Karin’s team is exploring to ultimately develop more effective treatments. | Genentech
65.8K viewsOct 30, 2024
FacebookGenentech
1:28
In the latest episode of our #podcast, Kim Homan, our expert in complex in vitro systems delves into the exciting world of organoids (miniature 3D models of organs grown in a dish). Tune in to S5E07 to learn how organoids can be used to better understand diverse cell types and the mechanisms by which diseases develop differently in people. | Genentech
138.6K viewsSep 25, 2024
FacebookGenentech
0:27
I’m proud to join Stand Up To Cancer American Cancer Society, Genentech and Rally Health for #CancerScreenWeek! Join us and take the pledge at GetScreenedNow.org to find out what cancer screenings may be right for you. | Jordana Brewster
43.1K viewsDec 8, 2017
FacebookJordana Brewster
Retrogenix® Cell Microarray Technology
Oct 28, 2021
criver.com
Screen Your Lungs TV Spot, 'If That Was You Then, Get Your Lungs Screened Now' Song by O'Neal and The Dean Brothers
Aug 3, 2021
iSpot.tv
29:40
Episode 6: From NIH to Genentech to Entrepreneurship | Dr. Cori Gorman
91 views1 month ago
YouTubeEchoes of Blue
1:01
Building “Off-the-Shelf” Regenerative Cell Therapies: The Next Biotech Revolution | Brian Culley
332 views2 weeks ago
YouTubeProgress, Potential, and Possibilities
46:27
Building “Off-the-Shelf” Regenerative Cell Therapies: The Next Biotech Revolution | Brian Culley
3.4K views3 weeks ago
YouTubeProgress, Potential, and Possibilities
13:27
Genetec Overview
1.4K viewsAug 14, 2019
YouTubeMichael OConnor
2:05
Apoptotic Pathways
409.3K viewsNov 13, 2012
YouTubeGenentech
1:40
Angiogenic Signaling
91.4K viewsNov 13, 2012
YouTubeGenentech
9:29
HOW TO REPLACE A SMARTPHONE SCREEN!
823K viewsMar 11, 2014
YouTubeeverythingdiy
3:05
Apoptosis Animation
74.2K viewsOct 26, 2020
YouTubeXVIVO Scientific Animation
1:50
Freecell Solitaire
10.1K viewsOct 10, 2018
YouTubePozirk Games
1:50
The PI3K Signaling Pathway
153.9K viewsNov 13, 2012
YouTubeGenentech
1:54
The MAPK Signaling Pathway
214.1K viewsNov 13, 2012
YouTubeGenentech
0:31
Double Freecell Solitaire
2.3K viewsDec 14, 2013
YouTubeFupaGames
See more
Static thumbnail place holder